Year |
Citation |
Score |
2023 |
Ramos A, Koch CE, Liu-Lupo Y, Hellinger RD, Kyung T, Abbott KL, Fröse J, Goulet D, Gordon KS, Eidell KP, Leclerc P, Whittaker CA, Larson RC, Muscato AJ, Yates KB, et al. Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening. Nature Communications. 14: 8048. PMID 38052854 DOI: 10.1038/s41467-023-43790-2 |
0.594 |
|
2023 |
Liu-Lupo Y, Ham JD, Jeewajee SKA, Nguyen L, Delorey T, Ramos A, Weinstock DM, Regev A, Hemann MT. Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia. Blood Cancer Journal. 13: 92. PMID 37286545 DOI: 10.1038/s41408-023-00863-1 |
0.594 |
|
2023 |
Gordon KS, Kyung T, Perez CR, Holec PV, Ramos A, Zhang AQ, Agarwal Y, Liu Y, Koch CE, Starchenko A, Joughin BA, Lauffenburger DA, Irvine DJ, Hemann MT, Birnbaum ME. Author Correction: Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains. Nature Biomedical Engineering. PMID 36737667 DOI: 10.1038/s41551-023-01006-4 |
0.482 |
|
2022 |
Gordon KS, Kyung T, Perez CR, Holec PV, Ramos A, Zhang AQ, Agarwal Y, Liu Y, Koch CE, Starchenko A, Joughin BA, Lauffenburger DA, Irvine DJ, Hemann MT, Birnbaum ME. Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains. Nature Biomedical Engineering. PMID 35710755 DOI: 10.1038/s41551-022-00896-0 |
0.553 |
|
2019 |
Wojtaszek JL, Chatterjee N, Najeeb J, Ramos A, Lee M, Bian K, Xue JY, Fenton BA, Park H, Li D, Hemann MT, Hong J, Walker GC, Zhou P. A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy. Cell. PMID 31178121 DOI: 10.1016/J.Cell.2019.05.028 |
0.586 |
|
2018 |
Ramos A, Barea LRM, Puissant A, Fenouille N, Alexe G, Stegmaier K, Hemann MT. Abstract 2358: Uncovering novel mechanisms of resistance in AML using integrative functional genomics Cancer Research. 78: 2358-2358. DOI: 10.1158/1538-7445.Am2018-2358 |
0.617 |
|
2017 |
Ramos A, Hemann MT. Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer. Cell. 170: 411-413. PMID 28753421 DOI: 10.1016/J.Cell.2017.07.018 |
0.544 |
|
2017 |
Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, Pikman Y, Conway AS, Burgess MR, Li Q, Luciano F, Auberger P, Galinsky I, DeAngelo DJ, Stone RM, et al. The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia. Nature Medicine. PMID 28191887 DOI: 10.1038/Nm.4283 |
0.648 |
|
2016 |
Pikman Y, Puissant A, Alexe G, Furman A, Chen LM, Frumm SM, Ross L, Fenouille N, Bassil CF, Lewis CA, Ramos A, Gould J, Stone RM, DeAngelo DJ, Galinsky I, et al. Targeting MTHFD2 in acute myeloid leukemia. The Journal of Experimental Medicine. PMID 27325891 DOI: 10.1084/Jem.20151574 |
0.651 |
|
2016 |
Lindblad O, Cordero E, Puissant A, Macaulay L, Ramos A, Kabir NN, Sun J, Vallon-Christersson J, Haraldsson K, Hemann MT, Borg Å, Levander F, Stegmaier K, Pietras K, Rönnstrand L, et al. Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML. Oncogene. PMID 26999641 DOI: 10.1038/Onc.2016.41 |
0.607 |
|
2016 |
Puissant A, Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, Pikman Y, Burgess MR, Li Q, Luciano F, Auberger P, Galinsky I, DeAngelo DJ, Stone RM, et al. Targeting the Creatine Kinase Pathway in EVI1-Positive Acute Myeloid Leukemia Blood. 128: 523-523. DOI: 10.1182/Blood.V128.22.523.523 |
0.653 |
|
2015 |
Puissant A, Fenouille N, Bassil CF, Ben-Sahra I, Alexe G, Benajiba L, Ramos A, Pikman Y, Burgess MR, Galinsky I, DeAngelo DJ, Stone RM, Shannon K, Hemann MT, Stegmaier K. Identification of CKMT1B As a New Target in EVI1-Positive AML Blood. 126: 3674-3674. DOI: 10.1182/Blood.V126.23.3674.3674 |
0.641 |
|
2014 |
Sun J, Ramos A, Chapman B, Johnnidis JB, Le L, Ho YJ, Klein A, Hofmann O, Camargo FD. Clonal dynamics of native haematopoiesis. Nature. 514: 322-7. PMID 25296256 DOI: 10.1038/Nature13824 |
0.335 |
|
2012 |
Ramos A, Camargo FD. The Hippo signaling pathway and stem cell biology. Trends in Cell Biology. 22: 339-46. PMID 22658639 DOI: 10.1016/J.Tcb.2012.04.006 |
0.345 |
|
Show low-probability matches. |